Global Genome Editing Market to Reach US$ 26.5 Billion by 2034 at a CAGR of 15.7%: A Revolution in Biomedicine | Future Market Insights Inc. [Yahoo! Finance]
Editas Medicine, Inc. (EDIT)
Last editas medicine, inc. earnings: 2/26 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.editasmedicine.com
Company Research
Source: Yahoo! Finance
Technology advancements and an expanding hospital infrastructure are expected to increase the demand for genome editing in the United States. NEWARK, Del, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The genome editing market is predicted to reach US$ 6.2 billion by 2024. The market size is expected to reach US$ 26.5 billion by 2034, projected at a CAGR of 15.7% . The CRISPR-Cas9 genetic editing technology opens up the possibility of correcting or modifying genes that cause genetic disorders. A potential breakthrough in treating cancer may be possible with the use of genome editing, which enables the targeting and modification of cancer cells. With genome editing, crops can be developed that produce more, are more resistant to pests, and have higher nutritional values. A healthier and more productive livestock can be produced by editing its genome. The genome editing process facilitates identifying and validating potential drug targets, which facilitates the discovery and development of ne
Show less
Read more
Impact Snapshot
Event Time:
EDIT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EDIT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EDIT alerts
High impacting Editas Medicine, Inc. news events
Weekly update
A roundup of the hottest topics
EDIT
News
- Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events [Yahoo! Finance]Yahoo! Finance
- Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor EventsGlobeNewswire
- Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration [Yahoo! Finance]Yahoo! Finance
- Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell CollaborationGlobeNewswire
- Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting [Yahoo! Finance]Yahoo! Finance
EDIT
Earnings
- 2/28/24 - Beat
EDIT
Sec Filings
- 4/16/24 - Form DEFA14A
- 4/16/24 - Form DEF
- 4/10/24 - Form SC
- EDIT's page on the SEC website